{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:18:16Z","timestamp":1792466296513,"version":"4.5.0"},"reference-count":91,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004726","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004726","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p><jats:italic>Acinetobacter<\/jats:italic> spp., in particular <jats:italic>A. baumannii<\/jats:italic>, are opportunistic pathogens linked to nosocomial pneumonia (particularly ventilator-associated pneumonia), central-line catheter-associated blood stream infections, meningitis, urinary tract infections, surgical-site infections, and other types of wound infections. <jats:italic>A. baumannii<\/jats:italic> is able to acquire or upregulate various resistance determinants, making it frequently multidrug-resistant, and contributing to increased mortality and morbidity. Data on the epidemiology, levels, and trends of antimicrobial resistance of <jats:italic>Acinetobacter<\/jats:italic> spp. in clinical settings is scarce in the Gulf Cooperation Council (GCC) and Middle East and North Africa (MENA) regions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective 12-year analysis of 17,564 non-duplicate diagnostic <jats:italic>Acinetobacter<\/jats:italic> spp. isolates from the United Arab Emirates (UAE) was conducted. Data was generated at 317 surveillance sites by routine patient care during 2010\u20132021, collected by trained personnel and reported by participating surveillance sites to the UAE National AMR Surveillance program. Data analysis was conducted with WHONET.<jats:xref><jats:sup>1<\/jats:sup><\/jats:xref><\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Species belonging to the <jats:italic>A. calcoaceticus-baumannii<\/jats:italic> complex were mostly reported (86.7%). They were most commonly isolated from urine (32.9%), sputum (29.0%), and soft tissue (25.1%). Resistance trends to antibiotics from different classes during the surveillance period showed a decreasing trend. Specifically, there was a significant decrease in resistance to imipenem, meropenem, and amikacin. Resistance was lowest among <jats:italic>Acinetobacter<\/jats:italic> species to both colistin and tigecycline. The percentages of multidrug-resistant (MDR) and possibly extensively drug-resistant (XDR) isolates was reduced by almost half between the beginning of the study in 2010 and its culmination in 2021. Carbapenem-resistant <jats:italic>Acinetobacter<\/jats:italic> spp. (CRAB) was associated with a higher mortality (RR: 5.7), a higher admission to ICU (RR 3.3), and an increased length of stay (LOS; 13 excess inpatient days per CRAB case), as compared to Carbapenem-susceptible <jats:italic>Acinetobacter<\/jats:italic> spp.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Carbapenem-resistant <jats:italic>Acinetobacter<\/jats:italic> spp. are associated with poorer clinical outcomes, and higher associated costs, as compared to carbapenem-susceptible <jats:italic>Acinetobacter<\/jats:italic> spp. A decreasing trend of MDR <jats:italic>Acinetobacter<\/jats:italic> spp., as well as resistance to all antibiotic classes under surveillance was observed during 2010 to 2021. Further studies are needed to explore the reasons and underlying factors leading to this remarkable decrease of resistance over time.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2023.1245131","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T17:54:51Z","timestamp":1704477291000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Epidemiology and antimicrobial resistance trends of Acinetobacter species in the United Arab Emirates: a retrospective analysis of 12\u2009years of national AMR surveillance data"],"prefix":"10.3389","volume":"11","author":[{"given":"Jens","family":"Thomsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najiba M.","family":"Abdulrazzaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussain","family":"AlRand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The UAE AMR Surveillance Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fmicb.2016.00049","article-title":"Reservoirs of non-baumannii Acinetobacter species","volume":"7","author":"Al Atrouni","year":"2016","journal-title":"Front Microbiol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s150100070013","article-title":"Community-acquired Acinetobacter meningitis in adults","volume":"28","author":"Chang","year":"2000","journal-title":"Infection"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1002\/iub.534","article-title":"Acinetobacter infection--an emerging threat to human health","volume":"63","author":"Visca","year":"2011","journal-title":"IUBMB Life"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1128\/CMR.00058-16","article-title":"Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges","volume":"30","author":"Wong","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.mimet.2015.09.006","article-title":"Species identification within Acinetobacter calcoaceticus-baumannii complex using MALDI-TOF MS","volume":"118","author":"Toh","year":"2015","journal-title":"J Microbiol Methods"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1136\/jcp.s2-3.1.82","article-title":"Analysis of hospital bacteriological data","volume":"3","author":"Stirland","year":"1969","journal-title":"J Clin Pathol Suppl Coll Pathol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/oxfordjournals.aje.a112548","article-title":"Acinetobacter calcoaceticus outbreak associated with peritoneal dialysis","volume":"107","author":"Abrutyn","year":"1978","journal-title":"Am J Epidemiol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1097\/CCM.0000000000000181","article-title":"The deadly impact of extreme drug resistance in Acinetobacter baumannii","volume":"42","author":"Spellberg","year":"2014","journal-title":"Crit Care Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1086\/529198","article-title":"Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options","volume":"46","author":"Maragakis","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1080\/22221751.2019.1698273","article-title":"The incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, eastern Mediterranean and Africa: a systematic review and meta-analysis","volume":"8","author":"Ayobami","year":"2019","journal-title":"Emerg Microbes Infect"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jinf.2019.09.012","article-title":"The global prevalence of multidrug-resistance among Acinetobacter baumannii causing hospital-acquired and ventilator-associated pneumonia and its associated mortality: a systematic review and meta-analysis","volume":"79","author":"Mohd Sazlly Lim","year":"2019","journal-title":"J Infect"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2478\/pjs-2013-0075","article-title":"Acinetobacter baumannii nosocomial infections","volume":"85","author":"Sieniawski","year":"2013","journal-title":"Pol Przegl Chir"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.4161\/viru.19700","article-title":"Acinetobacter baumannii","volume":"3","author":"Howard","year":"2012","journal-title":"Virulence"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.11604\/pamj.2016.23.191.7915","article-title":"Acinetobacter infections prevalence and frequency of the antibiotics resistance: comparative study of intensive care units versus other hospital units","volume":"23","author":"Uwingabiye","year":"2016","journal-title":"Pan Afr Med J"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4068\/cmj.2014.50.2.37","article-title":"Update on the epidemiology, treatment, and outcomes of Carbapenem-resistant Acinetobacter infections","volume":"50","author":"Kim","year":"2014","journal-title":"Chonnam Med J"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1017\/ice.2016.174","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014","volume":"37","author":"Weiner","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"7318075","DOI":"10.1155\/2016\/7318075","article-title":"Antibiotic-resistant Acinetobacter baumannii increasing success remains a challenge as a nosocomial pathogen","volume":"2016","author":"Gonzalez-Villoria","year":"2016","journal-title":"J Pathog"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9030119","article-title":"Insights into Acinetobacter baumannii: a review of microbiological, virulence, and resistance traits in a threatening nosocomial pathogen","volume":"9","author":"Ayoub Moubareck","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fcimb.2017.00055","article-title":"Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options","volume":"7","author":"Lee","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.5603\/FHC.a2016.0009","article-title":"Acinetobacter baumannii: biology and drug resistance - role of carbapenemases","volume":"54","author":"Nowak","year":"2016","journal-title":"Folia Histochem Cytobiol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1007\/s11033-020-05389-4","article-title":"Genetic mechanisms of antibiotic resistance and virulence in Acinetobacter baumannii: background, challenges and future prospects","volume":"47","author":"Chakravarty","year":"2020","journal-title":"Mol Biol Rep"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1080\/21505594.2018.1460187","article-title":"Phenotypic changes associated with Colistin resistance due to lipopolysaccharide loss in Acinetobacter baumannii","volume":"9","author":"Carretero-Ledesma","year":"2018","journal-title":"Virulence"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jhin.2020.09.009","article-title":"Excess mortality due to pandrug-resistant Acinetobacter baumannii infections in hospitalized patients","volume":"106","author":"Karakonstantis","year":"2020","journal-title":"J Hosp Infect"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1099\/jmm.0.000144","article-title":"Combined therapy for multi-drug-resistant Acinetobacter baumannii infection--is there evidence outside the laboratory?","volume":"64","author":"Tuon","year":"2015","journal-title":"J Med Microbiol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s10096-019-03784-9","article-title":"Treatment pattern, prognostic factors, and outcome in patients with infection due to pan-drug-resistant gram-negative bacteria","volume":"39","author":"Kofteridis","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3390\/pathogens12020286","article-title":"Efficacy of Fosfomycin-containing regimens for treatment of bacteremia due to Pan-drug resistant Acinetobacter baumannii in critically ill patients: a case series study","volume":"12","author":"Assimakopoulos","year":"2023","journal-title":"Pathogens"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/tropicalmed8020108","article-title":"Occurrence of multidrug-resistant strains of Acinetobacter spp.: An emerging threat for nosocomial-borne infection in Najran region, KSA","volume":"8","author":"Aedh","year":"2023","journal-title":"Trop Med Infect Dis"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.nmni.2016.02.006","article-title":"Emergence of multidrug-resistant Acinetobacter baumannii producing OXA-23 Carbapenemase in Qatar","volume":"11","author":"Rolain","year":"2016","journal-title":"New Microbes New Infect"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1089\/mdr.2020.0106","article-title":"Antimicrobial resistance of serial isolates of Acinetobacter baumannii colonizing the rectum of adult intensive care unit patients in a teaching Hospital in Kuwait","volume":"27","author":"Al-Hashem","year":"2021","journal-title":"Microb Drug Resist"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e00264","DOI":"10.1128\/genomeA.00264-18","article-title":"Draft genome sequences of six multidrug-resistant clinical strains of Acinetobacter baumannii, isolated at two major hospitals in Kuwait","volume":"6","author":"Nasser","year":"2018","journal-title":"Genome Announc"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3389\/fmicb.2015.00743","article-title":"Diversity of multi-drug resistant Acinetobacter baumannii population in a major hospital in Kuwait","volume":"6","author":"Vali","year":"2015","journal-title":"Front Microbiol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jgar.2020.11.016","article-title":"Detection of OXA-23, GES-11 and NDM-1 among carbapenem-resistant Acinetobacter baumannii in Dubai: a preliminary study","volume":"24","author":"Ayoub Moubareck","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1099\/jmm.0.055681-0","article-title":"Characteristics of epidemic and sporadic strains of Acinetobacter baumannii isolated in Abu Dhabi hospitals","volume":"62","author":"Sonnevend","year":"2013","journal-title":"J Med Microbiol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"479","DOI":"10.26719\/2011.17.6.479","article-title":"Rising bacterial resistance to common antibiotics in Al Ain, United Arab Emirates","volume":"17","author":"Al-Kaabi","year":"2011","journal-title":"East Mediterr Health J"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1089\/mdr.2010.0052","article-title":"Acinetobacter baumannii 2002-2008: increase of carbapenem-associated multiclass resistance in the United States","volume":"16","author":"Mera","year":"2010","journal-title":"Microb Drug Resist"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1128\/AAC.01665-09","article-title":"Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system","volume":"54","author":"Reddy","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jmii.2013.07.005","article-title":"Evolution of carbapenem resistance in Acinetobacter baumannii: an 18-year longitudinal study from a medical center in northern Taiwan","volume":"48","author":"Ku","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"ref39","first-page":"178","article-title":"Antimicrobial resistance of nosocomial strain of Acinetobacter baumannii in Children\u2019s medical Center of Tehran: a 6-year prospective study","volume":"48","author":"Soroush","year":"2010","journal-title":"Acta Med Iran"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1186\/s12879-019-4295-6","article-title":"Trends in antimicrobial resistance of bacterial pathogens in Harare, Zimbabwe, 2012-2017: a secondary dataset analysis","volume":"19","author":"Mhondoro","year":"2019","journal-title":"BMC Infect Dis"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/jpids\/piy018","article-title":"Acinetobacter baumannii resistance trends in children in the United States, 1999-2012","volume":"8","author":"Logan","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ijantimicag.2018.03.003","article-title":"Clonal emergence of Klebsiella pneumoniae ST14 co-producing OXA-48-type and NDM carbapenemases with high rate of colistin resistance in Dubai, United Arab Emirates","volume":"52","author":"Moubareck","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/jac\/dkab125","article-title":"Variation in approaches to antimicrobial use surveillance in high-income secondary care settings: a systematic review","volume":"76","author":"Patel","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1247627","DOI":"10.3389\/fpubh.2023.1247627","article-title":"Surveillance of antimicrobial resistance in the united emirates: the early implementation phase","volume":"11","author":"Thomsen","year":"2023","journal-title":"Front Public Health"},{"key":"ref45","volume-title":"Performance standards for antimicrobial susceptibility testing","year":"2020"},{"key":"ref46","unstructured":"2022"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13643-020-1279-y","article-title":"Social science research contributions to antimicrobial resistance: protocol for a scoping review","volume":"9","author":"Vedadhir","year":"2020","journal-title":"Syst Rev"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2471\/BLT.20.275875","article-title":"Social, cultural and economic aspects of antimicrobial resistance","volume":"98","author":"Minssen","year":"2020","journal-title":"Bull World Health Organ"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1515\/reveh-2017-0034","article-title":"The natural environment as a reservoir of pathogenic and non-pathogenic Acinetobacter species","volume":"33","author":"Adewoyin","year":"2018","journal-title":"Rev Environ Health"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1128\/CMR.00058-07","article-title":"Acinetobacter baumannii: emergence of a successful pathogen","volume":"21","author":"Peleg","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/jobm.201100323","article-title":"Ubiquitous Acinetobacter species as beneficial commensals but gradually being emboldened with antibiotic resistance genes","volume":"52","author":"Adegoke","year":"2012","journal-title":"J Basic Microbiol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.ARBA-0007-2017","article-title":"Antimicrobial resistance in Acinetobacter spp. and Pseudomonas spp","volume":"6","author":"Lupo","year":"2018","journal-title":"Microbiol Spectr"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1179\/1973947815Y.0000000037","article-title":"Antibiotic susceptibility of Acinetobacter species in intensive care unit in Montenegro","volume":"28","author":"Mijovic","year":"2016","journal-title":"J Chemother"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"860","DOI":"10.31729\/jnma.7088","article-title":"Extensive drug resistant Acinetobacter species isolates in sputum sample of patient admitted in intensive care unit of a tertiary care Centre: a descriptive cross-sectional study","volume":"59","author":"Prasai","year":"2021","journal-title":"JNMA J Nepal Med Assoc"},{"key":"ref55","first-page":"1547","article-title":"Carbapenemases among Acinetobacter species isolated from NICU of a tertairy care hospital in Karachi","volume":"67","author":"Indhar","year":"2017","journal-title":"J Pak Med Assoc"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12941-022-00536-0","article-title":"Insight into carbapenem resistance and virulence of Acinetobacter baumannii from a children\u2019s medical Centre in eastern China","volume":"21","author":"Zhu","year":"2022","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3760\/cma.j.cn112140-20210117-00053","article-title":"Drug resistance of Acinetobacter baumannii in pediatric intensive care unit","volume":"59","author":"Xu","year":"2021","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"e0072521","DOI":"10.1128\/mSphere.00725-21","article-title":"Deciphering multidrug-resistant Acinetobacter baumannii from a pediatric Cancer Hospital in Egypt","volume":"6","author":"Jalal","year":"2021","journal-title":"mSphere"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s13104-021-05826-y","article-title":"Community acquired Acinetobacter baumannii in pediatric patients under 1 year old with a clinical diagnosis of whooping cough in Lima","volume":"14","author":"Pe\u00f1a-Tuesta","year":"2021","journal-title":"Peru BMC Res Notes"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"312","DOI":"10.22037\/uj.v0i0.4256","article-title":"The epidemiology of symptomatic catheter-associated urinary tract infections in the intensive care unit: a 4-year single center retrospective study","volume":"16","author":"Ding","year":"2019","journal-title":"Urol J"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1038\/s41467-019-10706-y","article-title":"Urinary tract colonization is enhanced by a plasmid that regulates uropathogenic Acinetobacter baumannii chromosomal genes","volume":"10","author":"Di Venanzio","year":"2019","journal-title":"Nat Commun"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.micpath.2018.12.023","article-title":"Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients","volume":"128","author":"Jain","year":"2019","journal-title":"Microb Pathog"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"e802","DOI":"10.1016\/j.ijid.2013.03.021","article-title":"Reservoirs of Acinetobacter baumannii outside the hospital and potential involvement in emerging human community-acquired infections","volume":"17","author":"Eveillard","year":"2013","journal-title":"Int J Infect Dis"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"254","DOI":"10.4103\/sjmms.sjmms_855_20","article-title":"Antibiotic resistance pattern of Acinetobacter baumannii strains: a retrospective study from Oman","volume":"9","author":"Sannathimmappa","year":"2021","journal-title":"Saudi J Med Med Sci"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1128\/JCM.02784-14","article-title":"Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates in the Gulf cooperation council states: dominance of OXA-23-type producers","volume":"53","author":"Zowawi","year":"2015","journal-title":"J Clin Microbiol"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"106324","DOI":"10.1016\/j.ijantimicag.2021.106324","article-title":"Increased antimicrobial resistance during the COVID-19 pandemic","volume":"57","author":"Lai","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.3390\/v13112110","article-title":"Impact of SARS-CoV-2 epidemic on antimicrobial resistance: a literature review","volume":"13","author":"Segala","year":"2021","journal-title":"Viruses"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"823626","DOI":"10.3389\/fcimb.2022.823626","article-title":"The collateral effects of COVID-19 pandemic on the status of Carbapenemase-producing pathogens","volume":"12","author":"Ayoub Moubareck","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13756-020-0678-0","article-title":"Ten-year resistance trends in pathogens causing healthcare-associated infections; reflection of infection control interventions at a multi-hospital healthcare system in Saudi Arabia, 2007-2016","volume":"9","author":"Balkhy","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"106689","DOI":"10.1016\/j.ijantimicag.2022.106689","article-title":"Study group \u201cantimicrobial resistance\u201d of the Paul-Ehrlich-Society for Infection Therapy. The evolution of carbapenem resistance determinants and major epidemiological lineages among carbapenem-resistant Acinetobacter baumannii isolates in Germany, 2010-2019","volume":"60","author":"Wohlfarth","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ijid.2003.11.009","article-title":"Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY antimicrobial surveillance program","volume":"8","author":"Tognim","year":"2004","journal-title":"Int J Infect Dis"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jiph.2021.02.011","article-title":"Antimicrobial resistance threats in the emerging COVID-19 pandemic: where do we stand?","volume":"14","author":"Ghosh","year":"2021","journal-title":"J Infect Public Health"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3390\/microorganisms10050849","article-title":"Multidrug-resistant Acinetobacter baumannii in Jordan","volume":"10","author":"al-Tamimi","year":"2022","journal-title":"Microorganisms"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jgar.2021.08.005","article-title":"Phenotypic and genotypic characterisation of cephalosporin-, carbapenem- and colistin-resistant gram-negative bacterial pathogens in Lebanon, Jordan and Iraq","volume":"27","author":"Moghnieh","year":"2021","journal-title":"J Global Antimicrob Resist."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1600-0463.2012.02935.x","article-title":"Investigation of Acinetobacter baumannii resistance to carbapenems in Marseille hospitals, south of France: a transition from an epidemic to an endemic situation","volume":"121","author":"Kempf","year":"2013","journal-title":"APMIS"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ijantimicag.2011.10.004","article-title":"Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options","volume":"39","author":"Kempf","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"e8976","DOI":"10.5812\/jjm.8976","article-title":"Evaluation of ciprofloxacin (gyrA, parC genes) and tetracycline (tetB gene) resistance in nosocomial Acinetobacter baumannii infections","volume":"7","author":"Nowroozi","year":"2014","journal-title":"Jundishapur J Microbiol"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2174\/1874285801812010116","article-title":"Molecular study of quinolone resistance determining regions of gyrA gene and parC genes in clinical isolates of Acintobacter baumannii resistant to fluoroquinolone","volume":"12","author":"Zaki","year":"2018","journal-title":"Open Microbiol J"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3855\/jidc.11410","article-title":"Molecular mechanisms of antibiotic co-resistance among carbapenem resistant Acinetobacter baumannii","volume":"13","author":"Khurshid","year":"2019","journal-title":"J Infect Dev Ctries"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/jac\/dkx368","article-title":"Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis","volume":"73","author":"Kengkla","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jgar.2015.12.003","article-title":"Successful treatment of postoperative multidrug-resistant Acinetobacter baumannii meningitis by tigecycline","volume":"5","author":"Kooli","year":"2016","journal-title":"J Glob Antimicrob Resist"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jgar.2020.08.021","article-title":"Comparative efficacy and safety of combination therapy with high-dose sulbactam or colistin with additional antibacterial agents for multiple drug-resistant and extensively drug-resistant Acinetobacter baumannii infections: a systematic review and network meta-analysis","volume":"24","author":"Liu","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s10096-022-04503-7","article-title":"In vitro and in vivo efficacy of cefiderocol plus tigecycline, colistin, or meropenem against carbapenem-resistant Acinetobacter baumannii","volume":"41","author":"Ni","year":"2022","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.clineuro.2018.06.008","article-title":"Tigecycline in the treatment of multidrug-resistant Acinetobacter baumannii meningitis: results of the Ege study","volume":"172","author":"Sipahi","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"key":"ref85","first-page":"459","article-title":"In-vitro assessment of the therapeutic potential of Polymyxins and Tigecycline against Multidrugresistant Acinetobacter isolates from infected wounds","volume":"32","author":"Khurshid","year":"2020","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"e0133322","DOI":"10.1128\/spectrum.01333-22","article-title":"Identification of novel tet(X3) variants resistant to Tigecycline in Acinetobacter species","volume":"10","author":"Cheng","year":"2022","journal-title":"Microbiol Spectr"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"e2000014","DOI":"10.1002\/bies.202000014","article-title":"Emerging high-level Tigecycline resistance: novel tetracycline Destructases spread via the Mobile Tet(X)","volume":"42","author":"Fang","year":"2020","journal-title":"Bioessays"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3390\/antibiotics12030516","article-title":"Colistin resistance in Acinetobacter baumannii: molecular mechanisms and epidemiology","volume":"12","author":"Novovi\u0107","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jgar.2021.03.002","article-title":"Characterisation of mcr-4.3 in a colistin-resistant Acinetobacter nosocomialis clinical isolate from Cape Town, South Africa","volume":"25","author":"Snyman","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1186\/s12879-022-07436-w","article-title":"Epidemiology and outcomes associated with carbapenem-resistant Acinetobacter baumannii and carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study","volume":"22","author":"Vivo","year":"2022","journal-title":"BMC Infect Dis"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/antibiotics9080514","article-title":"Clinical and economic burden of Carbapenem-resistant infection or colonization caused by Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii: a multicenter study in China","volume":"9","author":"Zhen","year":"2020","journal-title":"Antibiotics (Basel)"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1245131\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T17:55:03Z","timestamp":1704477303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1245131\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":91,"alternative-id":["10.3389\/fpubh.2023.1245131"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1245131","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,4]]},"article-number":"1245131"}}